Lansforsakringar Fondforvaltning’s AbbVie ABBV Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$147M	Buy	583,795 +17,609	+3%	+$3.79M	0.66%	27
2026 Q1	$123M	Sell	566,186 -39,973	-7%	-$8.87M	0.64%	19
2025 Q4	$139M	Buy	606,159 +49,661	+9%	+$11.3M	0.69%	19
2025 Q3	$129M	Buy	556,498 +14,162	+3%	+$2.88M	0.67%	20
2025 Q2	$101M	Sell	542,336 -27,733	-5%	-$5.15M	0.58%	26
2025 Q1	$119M	Sell	570,069 -17,141	-3%	-$3.33M	0.73%	22
2024 Q4	$104M	Buy	+587,210	New	+$108M	0.58%	27

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Lansforsakringar Fondforvaltning's ABBV Position: Q2 2026 in Review

Lansforsakringar Fondforvaltning increased its AbbVie (ABBV) stake by 3.1% in Q2 2026, buying an estimated $3.79M and bringing the position to 583,795 shares worth $147M. The position accounts for 0.66% of the portfolio, ranked #27.

Lansforsakringar Fondforvaltning first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Lansforsakringar Fondforvaltning held 583,795 shares of AbbVie worth $147M as of Q2 2026.
Lansforsakringar Fondforvaltning bought 17,609 AbbVie shares in Q2 2026, an estimated $3.79M.
AbbVie made up 0.66% of Lansforsakringar Fondforvaltning's portfolio in Q2 2026, its #27 holding.
Lansforsakringar Fondforvaltning first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q2 2026, filed 13 Aug 2026.